Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 851 of 1,261
  1. US 8541587

    Lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  2. US 8541548

    Compounds and methods for reversible modification of biologically active molecules

    Arrowhead Madison, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  3. US 8541482

    Removable multilayer nail coating system and methods therefore

    Creative Nail Design Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  4. US 8541608

    Method for preparing a polymer conjugate

    Nektar Therapeutics · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  5. US 8541597

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  6. US 8541451

    Crystalline freebase forms of a biphenyl compound

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  7. US 8541456

    Roflumilast for the treatment of diabetes mellitus type 2

    TAKEDA GMBH · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  8. US 8541453

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  9. US 8541445

    Pyrazolopyridines

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  10. US 8541475

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  11. US 8541457

    Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  12. US 8541185

    Method of predicting responsiveness to autologous adoptive cell transfer therapy

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  13. US 8541373

    BChE albumin fusions for the treatment of cocaine abuse

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  14. US 8540997

    Complement receptor 1 and 2 fusion proteins

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  15. US 8541203

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  16. US 8541025

    Co-crystals and pharmaceutical formulations comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  17. US 8541182

    Biological marker for inflammation

    CAN-FITE BIOPHARMA LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  18. US 8541375

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  19. US 8541024

    Film-coated scored tablet

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  20. US 8541458

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  21. US 8541221

    Primate T-lymphotropic viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  22. CA 2859273

    POLYMERES CATIONIQUES A BASE DE GLYCOGENE

    ACRAF [IT] · Granted Sep 19, 2013 · Expires Sep 14, 2033

    granted
  23. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted
  24. US 8536165

    Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

    Almirall, S.A. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.